CoVPN Logo (IMAGE)
Caption
The COVID-19 Prevention Network (CoVPN) today announced two Phase 3 trials to determine whether monoclonal antibodies (mAbs) can prevent SARS-CoV-2, the virus that causes COVID-19.
Credit
CoVPN
Usage Restrictions
None
License
Licensed content